Sarah Faust

Sarah Faust brings over 30 years of US and global pharmaceutical and biotech industry experience to the BiologicsMD Advisory Team. With a proven commercial strategy and brand development track record, Sarah has successfully launched and grown multi-million to multi-billion-dollar brands in various healthcare settings. Her expertise includes business planning, strategic consulting, and commercial assessments. Sarah serves as Chief Commercial Officer for Neumentum and provides strategic expertise to ThirdLaw Molecular.

Dr. Nancy M. Ruiz, MD, FACP, FIDSA

Dr. Nancy M. Ruiz brings over 25 years of global experience in drug development to the BiologicsMD Advisory Team. As a board-certified physician and strategic leader, Dr. Ruiz has spearheaded the development of numerous small molecules and biologics across various therapeutic areas.

Her cross-functional expertise spans research, clinical development, regulatory affairs, and medical affairs. Dr. Ruiz has held prominent positions at leading pharmaceutical companies, including Vice-President Pipeline & Portfolio Management at Merck Research Labs, Schering Plough Pharmaceuticals and Chief Medical Officer at Meda Pharmaceuticals and  Larimar Therapeutics. She is a Fellow of the American College of Physicians and the Infectious Disease Society of America.